Fléchon A - Search Results

1

Personalised chemotherapy based on tumour marker decline in poor prognosis germ-cell tumours (GETUG 13): a phase 3, multicentre, randomised trial.

Fizazi K, Pagliaro L, Laplanche A, Fléchon A, Mardiak J, Geoffrois L, Kerbrat P, Chevreau C, Delva R, Rolland F, Theodore C, Roubaud G, Gravis G, Eymard JC, Malhaire JP, Linassier C, Habibian M, Martin AL, Journeau F, Reckova M, Logothetis C, Culine S. Fizazi K, et al. Among authors: flechon a. Lancet Oncol. 2014 Dec;15(13):1442-1450. doi: 10.1016/S1470-2045(14)70490-5. Epub 2014 Nov 13. Lancet Oncol. 2014. PMID: 25456363 Free PMC article. Clinical Trial.

2

[High dose chemotherapy with autologous stem cell support in the treatment of germ cell tumors: experience of the centre Léon-Bérard between 1982 and 1996].

Fléchon A, Biron P, Philip I, Blay JY, Droz JP. Fléchon A, et al. Bull Cancer. 1999 Apr;86(4):391-9. Bull Cancer. 1999. PMID: 10341344 Free article. French.

3

[Germ cell tumors of the testes: state of the art].

Fléchon A, Droz JP. Fléchon A, et al. Cancer Radiother. 2000 Jan-Feb;4(1):27-31. doi: 10.1016/S1278-3218(00)88649-7. Cancer Radiother. 2000. PMID: 10742806 French.

4

Intensive and timely chemotherapy, the key of success in testicular cancer.

Fléchon A, Culine S, Droz JP. Fléchon A, et al. Crit Rev Oncol Hematol. 2001 Jan;37(1):35-46. doi: 10.1016/s1040-8428(00)00074-3. Crit Rev Oncol Hematol. 2001. PMID: 11164717 Review.

5

Viable malignant cells after primary chemotherapy for disseminated nonseminomatous germ cell tumors: prognostic factors and role of postsurgery chemotherapy--results from an international study group.

Fizazi K, Tjulandin S, Salvioni R, Germà-Lluch JR, Bouzy J, Ragan D, Bokemeyer C, Gerl A, Fléchon A, de Bono JS, Stenning S, Horwich A, Pont J, Albers P, De Giorgi U, Bower M, Bulanov A, Pizzocaro G, Aparicio J, Nichols CR, Théodore C, Hartmann JT, Schmoll HJ, Kaye SB, Culine S, Droz JP, Mahé C. Fizazi K, et al. Among authors: flechon a. J Clin Oncol. 2001 May 15;19(10):2647-57. doi: 10.1200/JCO.2001.19.10.2647. J Clin Oncol. 2001. PMID: 11352956

6

Importance of surgery as salvage treatment after high dose chemotherapy failure in germ cell tumors.

Fléchon A, Rivoire M, Biron P, Droz JP. Fléchon A, et al. J Urol. 2001 Jun;165(6 Pt 1):1920-6. doi: 10.1097/00005392-200106000-00019. J Urol. 2001. PMID: 11371882

7

[Is still there an indication for high-dose chemotherapy with hematopoietic stem-cell support in the treatment of germ-cell tumors?].

Fléchon A, Droz JP. Fléchon A, et al. Bull Cancer. 2001 Sep;88(9):852-7. Bull Cancer. 2001. PMID: 11604357 Free article. Review. French.

8

Management of clinical stage I nonseminomatous germ-cell testis tumors.

Flechon A, Droz JP. Flechon A, et al. Expert Rev Anticancer Ther. 2003 Feb;3(1):21-30. doi: 10.1586/14737140.3.1.21. Expert Rev Anticancer Ther. 2003. PMID: 12597346 Review.

9

Pattern of relapse after first line treatment of advanced stage germ-cell tumors.

Fléchon A, Culine S, Théodore C, Droz JP. Fléchon A, et al. Eur Urol. 2005 Dec;48(6):957-63; discussion 963-4. doi: 10.1016/j.eururo.2005.06.018. Epub 2005 Jul 18. Eur Urol. 2005. PMID: 16084010

10

The risk of thrombo-embolic events is increased in patients with germ-cell tumours and can be predicted by serum lactate dehydrogenase and body surface area.

Piketty AC, Fléchon A, Laplanche A, Nouyrigat E, Droz JP, Théodore C, Fizazi K. Piketty AC, et al. Among authors: flechon a. Br J Cancer. 2005 Oct 17;93(8):909-14. doi: 10.1038/sj.bjc.6602791. Br J Cancer. 2005. PMID: 16205699 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

240 results

Search Page

Filters